Cognition in schizophrenia: impairments, determinants, and functional importance

The Psychiatric Clinics of North America
Christopher R Bowie, Philip D Harvey


Recent findings support and add to earlier findings of cognitive dysfunction in schizophrenia. Deficits across neurocognitive domains such as attention, working memory, language skills, and executive functioning tend to be moderate, with the most pronounced deficits found in verbal learning and memory. All these neurocognitive domains are related to adaptive and social skills, with executive functions and verbal learning and memory showing more variance across more domains than other neuro-cognitive variables. Negative symptoms and neurocognitive domains, although correlated, are distinct and have differential pathways of change with treatment. General psychopathology symptoms, such as depression and anxiety, may become important treatment targets as strategies are developed for translating cognitive enhancement to real-world functional performance.


Feb 18, 2006·Proceedings of the National Academy of Sciences of the United States of America·Hiroko KoikeJoseph A Gogos
Jul 10, 2014·American Journal on Intellectual and Developmental Disabilities·Lyn S TurkstraPeter Meulenbroek
Mar 3, 2009·The British Journal of Psychiatry : the Journal of Mental Science·Jonathan SavitzRajkumar Ramesar
Feb 24, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·José A Apud, Daniel R Weinberger
Aug 4, 2006·Schizophrenia Bulletin·Alex KopelowiczRoberto Zarate
Aug 15, 2006·Schizophrenia Bulletin·Mario PfammatterHans Dieter Brenner
Jun 27, 2007·The Journal of Clinical Psychiatry·Risa B Gershon GrandArthur L Brody
Jul 10, 2007·Schizophrenia Bulletin·John A Gray, Bryan L Roth
Jul 20, 2007·Schizophrenia Bulletin·Sharon Morein-ZamirBarbara J Sahakian
Feb 5, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Margaret M McClureLarry J Siever
Jun 28, 2011·Annals of General Psychiatry·Sofia BrissosMaria Luísa Figueira
Dec 17, 2009·The Australian and New Zealand Journal of Psychiatry·Brian Dean
Feb 5, 2013·Applied Neuropsychology. Adult·Robert M RothLaura A Flashman
Mar 4, 2010·Journal of Clinical and Experimental Neuropsychology·Lisa A DukeJason Schwartz
Feb 23, 2011·Community Mental Health Journal·Marina EconomouMichael Madianos
Oct 10, 2006·Journal of Autism and Developmental Disorders·Sven BölteLutz Schmidt
Jul 16, 2008·Cognitive Neuropsychiatry·Annie St-HilaireNancy M Docherty
Jul 22, 2010·Brain : a Journal of Neurology·Boris SchifferElke R Gizewski
Apr 8, 2014·Journal of Neurogenetics·Charmaine Y PietersenTsung-Ung W Woo
Apr 23, 2011·Expert Opinion on Investigational Drugs·Niels PlathJohn Paul Redrobe
Jul 2, 2015·Schizophrenia Research·Megan M FredrickDawn I Velligan
Aug 30, 2012·The Psychiatric Clinics of North America·Philip D Harvey, Christopher R Bowie
Jul 14, 2010·Progress in Neurobiology·Matthijs G Bossong, Raymond J M Niesink
Mar 5, 2016·Journal of Autism and Developmental Disorders·Maria MarinopoulouEva Billstedt
Oct 27, 2009·Schizophrenia Research·Roberto Rodriguez-JimenezPARG
Feb 13, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Paola RoccaFilippo Bogetto
Dec 3, 2008·Psychiatry Research·Adriano ZanelloMarco C G Merlo
Sep 16, 2008·Schizophrenia Research·Shahin AkhondzadehSaeedeh Forghani
Aug 30, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Shahin AkhondzadehSams-Ali Rezazadeh
Aug 24, 2007·Biochemical Pharmacology·Ann Olincy, Karen E Stevens
Nov 25, 2015·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Sung-Jin KimDo-Un Jung
May 4, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Shin-Min LeeMao-Hsiung Yen


Dec 1, 1992·Archives of General Psychiatry·M S BuchsbaumP A Jerabek
Dec 1, 1992·Archives of General Psychiatry·S Park, P S Holzman
Nov 1, 1991·Journal of Clinical and Experimental Neuropsychology·S W AndersonD Tranel
Jul 1, 1991·Archives of General Psychiatry·A J SaykinP Stafiniak
Jan 1, 1990·The Journal of Neuropsychiatry and Clinical Neurosciences·T E GoldbergD R Weinberger
Feb 1, 1990·The British Journal of Psychiatry : the Journal of Mental Science·M S BuchsbaumS Guich
Jan 1, 1990·Schizophrenia Bulletin·Philip D HarveyM Rasmussen
Apr 1, 1986·The Journal of Nervous and Mental Disease·M F Green, E Walker
Feb 1, 1994·Archives of General Psychiatry·A J SaykinR C Gur
Jun 1, 1994·Archives of General Psychiatry·R K HeatonD V Jeste
Jan 1, 1994·The American Journal of Psychiatry·J J Blanchard, J M Neale
Dec 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·H A AllenC D Frith
Mar 1, 1996·The American Journal of Psychiatry·M F Green
Jul 5, 1996·Schizophrenia Research·D L PennM Sullivan
Jun 26, 1996·Psychiatry Research·P W CorriganR Toomey
Jun 1, 1996·Journal of Clinical and Experimental Neuropsychology·B N AxelrodG G Kay
Nov 1, 1996·Psychiatry Research·M W HautS M Bloomfield
Feb 1, 1997·Archives of General Psychiatry·J M GoldD R Weinberger
Mar 1, 1997·Psychological Medicine·G BrébionJ M Gorman
Feb 1, 1997·The British Journal of Psychiatry : the Journal of Mental Science·R M NormanL Cortese
May 24, 1997·Schizophrenia Research·J D StirlingJ Hewitt
Nov 20, 1997·Brain : a Journal of Neurology·C PantelisT W Robbins
Jul 1, 1996·Journal of the International Neuropsychological Society : JINS·M S AloiaT E Goldberg
Jan 1, 1995·Journal of the International Neuropsychological Society : JINS·J S PaulsenD V Jeste
Jun 5, 1998·Biological Psychiatry·K L DavisP Powchik
Aug 27, 1998·Schizophrenia Bulletin·I L FowlerT J Lewin
Dec 8, 1998·The American Journal of Psychiatry·T E GoldbergD R Weinberger
Feb 16, 1999·Schizophrenia Research·Philip D HarveyK L Davis
Sep 3, 1999·Psychological Medicine·R S KeefePhilip D Harvey
Sep 10, 1999·Schizophrenia Research·E A HolthausenR J Van den Bosch
Nov 26, 1999·European Psychiatry : the Journal of the Association of European Psychiatrists·H VolzH Sauer

Related Concepts

Antipsychotic Effect
Biochemical Pathway
Memory Loss
Acquired Language Disorders
Memory for Designs Test
Social Perception
Cognition Disorders
Verbal Learning

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.